4.7 Article

Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 202, Issue 10, Pages 1327-1332

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20051194

Keywords

-

Funding

  1. NIAID NIH HHS [U-19AI057229, P01AI063302, U19 AI057229, P01 AI063302] Funding Source: Medline

Ask authors/readers for more resources

The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor kappa B (NF- kappa B) and mitogen-activated protein kinase pathways, which might be important for evasion of the host immune response and aid in establishing a systemic infection. Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing ubiquitin moieties from critical proteins, such as TRAF2, TRAF6, and I kappa B alpha. In contrast to the cylindromatosis tumor suppressor CYLD, which attenuates NF-kappa B signaling by selectively removing K63-linked polyubiquitin chains that activate I kappa B kinase, YopJ also cleaves K48-linked chains and thereby inhibits proteasomal degradation of I kappa B alpha. YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular proteins and cleaved both K48- and K63- linked polyubiquitin. Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating activity of purified YopJ.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available